Targeted PSMA Radionuclide Drug Conjugates market
According to a new report from Intel Market Research, the global Targeted PSMA Radionuclide Drug Conjugates market was valued at USD 1,821 million in 2025 and is projected to reach USD 3,218 million by 2034, reflecting a robust CAGR of 8.3 % during the forecast horizon (2025–2034). This expansion is driven by a confluence of clinical, regulatory and commercial forces that are reshaping...
0 Reacties 0 aandelen 18 Views 0 voorbeeld
BuzzingAbout https://www.buzzingabout.com